Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005

Podobne zapisy

• Inhibition of allergen-induced airway obstruction and leukotriene generation in atopic asthmatic subjects by the leukotriene biosynthesis inhibitor BAYx 1005
  od: Dahlen, B., i wsp.
  Wydane: (1997)
• Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects
  od: Gauvreau, Gail M, i wsp.
  Wydane: (2011)
• Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses.
  od: Freitag, A, i wsp.
  Wydane: (1993)
• Effect of a novel 5-lipoxygenase activating protein inhibitor, BAYx 1005, on asthma induced by cold dry air
  od: Fischer, A. R., i wsp.
  Wydane: (1997)
• Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses.
  od: Nasser, S. M., i wsp.
  Wydane: (1994)